NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
申请人:Palani Anandan
公开号:US20110152259A1
公开(公告)日:2011-06-23
The present invention provides compounds of Formula (I):
and pharmaceutically acceptable salts, solvates, esters, and tautomers thereof, wherein:
Q is selected from the group consisting of:
and
L is selected from the group consisting of:
pharmaceutically compositions comprising one or more compounds of formula (I), and methods of using the compounds of formula (I).
HABIB, N. S.;KAPPE, T., MONATSH. CHEM., 1984, 115, N 12, 1459-1466
作者:HABIB, N. S.、KAPPE, T.
DOI:——
日期:——
COMBINATION THERAPIES COMPRISING PAR1 ANTAGONISTS WITH NAR AGONISTS
申请人:Perelman Michael Sidney
公开号:US20110065676A1
公开(公告)日:2011-03-17
The present invention is directed to a pharmaceutical composition comprising an effective amount of at least one PAR1 antagonist, at least one NAR agonist, optionally, an effective amount of at least one cardiovascular agent, and, optionally, a pharmaceutically acceptable carrier. The present invention also provides for the use of theses pharmaceutical compositions to treat various diseases associated with thrombosis.
Synthesis of 2H-pyrano[2,3-d]pyrimidine derivatives